<DOC>
	<DOCNO>NCT00185237</DOCNO>
	<brief_summary>150 postmenopausal Asian woman vasomotor symptom , fulfil inclusion exclusion criterion enrol study . The woman randomly assign one two treatment group ( MenostarÂ® placebo ) , ask use patch week 12 week .</brief_summary>
	<brief_title>Treatment Hot Flushes Asian Women With Ultra-low Dose Estradiol Patch</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Evidence postmenopausal status Contraindication estrogen therapy</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Menopause</keyword>
</DOC>